Liver embolization with trisacryl gelatin microspheres (Embosphere) in patients with neuroendocrine tumors

Acta Radiologica

Volumn 48, Issue 2, 2007, Pages 180-185

  Granberg, D ^a   Eriksson, L G ^a   Welin, S ^a   Kindmark, H ^a   Janson, E T ^a   Skogseid, B ^a   Oberg K ^a   Eriksson, B ^a   Nyman, R ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Embolization; Liver; Metastases

Indexed keywords

BIOCHEMISTRY; DISEASES; PATIENT TREATMENT; RADIOLOGY; TUMORS;

LIVER EMBOLIZATION; METASTASES; METASTATIC NEUROENDOCRINE TUMORS; TRISACRYL GELATIN MICROSPHERES;

MEDICAL PROBLEMS;

ACRYLIC ACID RESIN; GELATIN; TRISACRYL GELATIN MICROSPHERES; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; LIVER TUMOR; MALE; METASTASIS; METHODOLOGY; MIDDLE AGED; NEUROENDOCRINE TUMOR; RADIOGRAPHY; TREATMENT OUTCOME;

ACRYLIC RESINS; ADULT; AGED; EMBOLIZATION, THERAPEUTIC; FEMALE; GELATIN; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEUROENDOCRINE TUMORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 33947120671     PISSN: 02841851     EISSN: 16000455     Source Type: Journal    
DOI: 10.1080/02841850601080440     Document Type: Article

References (16)

1. Ahlman H, Olausson M. Cytoreduction of neuroendocrine tumors. In: Schwartz A, Pertsemidis D, Gagner M, editors. Endocrine surgery. New York: Marcel Dekker; 2003. p. 671-83.
2. Carrasco CH, Charnsangavej C, Ajani J, Samaan NA, Richli W, Wallace S. The carcinoid syndrome: palliation by hepatic artery embolization. Am J Roentgenol 1986;147:149-54.
3. Elias D, Lasser P, Ducreux M, Duvillard P, Ouellet J-F, Dromain C, et al. Liver resection (and associated extrahepatic resections) for metastatic well-differentiated endocrine tumors: a 15-year single center prospective study. Surgery 2003;133:375-82.
4. Eriksson BK, Larsson EG, Skogseid BM, Löfberg A-M, Lörelius L-E, Öberg KE. Liver embolizations of patients with malignant neuroendocrine gastrointestinal tumors. Cancer 1998;83:2293-301.
5. Gupta S, Johnson MM, Murthy R, Ahrar K, Wallace MJ, Madoff DC, et al. Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors. Cancer 2005;104:1590-602.
6. Gupta S, Yao JC, Ahrar K, Wallace MJ, Morello FA, Madoff DC, et al. Hepatic artery embolization and chemoembolization for treatment of patients with metastatic carcinoid tumors: the M.D. Anderson experience. Cancer J 2003;9:261-7.
7. Henn AR, Levine EA, McNulty W, Zagoria RJ. Percutaneous radiofrequency ablation of hepatic metastases for symptomatic relief of neuroendocrine syndromes. Am J Roentgenol 2003;181:1005-10.
8. Kress O, Wagner HJ, Wied M, Klose K, Arnold R, Alfke H. Transarterial chemoembolization of advanced liver metastases of neuroendocrine tumors - a retrospective single-center analysis. Digestion 2003;68:94-101.
9. O'Toole D, Maire F, Ruszniewski P. Ablative therapies for liver metastases of digestive endocrine tumours. Endocr Relat Cancer 2003;10:463-8.
10. Roche A, Girish BV, de Baere T, Baudin E, Boige V, Elias D, et al. Trans-catheter arterial chemoembolization as first-line treatment for hepatic metastases from endocrine tumors. Eur Radiol 2003;13:136-40.
11. Ruszniewski P, Malka D. Hepatic arterial chemoembolization in the management of advanced digestive endocrine tumors. Digestion 2000;62 Suppl 1:79-83.
12. Schell SR, Camp ER, Caridi JG, Hawkins IF Jr. Hepatic artery embolization for control of symptoms, octreotide requirements, and tumor progression in metastatic carcinoid tumors. J Gastrointest Surg 2002;6:664-70.
13. Sutcliffe R, Maguire D, Ramage J, Rela M, Heaton N. Management of neuroendocrine liver metastases. Am J Surg 2004;187:39-46.
14. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, et al. New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 2000;92:205-16.
15. Vallee J-N, Lo D, Guillevin R, Reb P, Adem C, Chiras J. In vitro study of the compatibility of tris-acryl gelatin microspheres with various chemotherapeutic agents. J Vasc Interv Radiol 2003;14:621-8.
16. Wängberg B, Westberg G, Tylen U, Tisell L, Jansson S, Nilsson O, et al. Survival of patients with disseminated midgut carcinoid tumors after aggressive tumor reduction. World J Surg 1996;20:892-9.